CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: A study of 64 patients with CP-CML, with higher BMI1 expression in CD34+ cells at diagnosis conferred a poorer prognosis and decreased survival than those with lower levels (Mohty et al., 2007).